You can find the annual or quarterly income statement of AN2 Therapeutics Inc here for insights into the performance and operational efficiency of AN2 Therapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Operating expenses

-14.71%10.04M

-54.56%7.22M

-36.94%11.54M

-54.25%8.61M

-35.25%11.77M

-4.34%15.88M

14.07%18.30M

50.81%18.82M

54.46%18.18M

60.66%16.60M

108.76%16.04M

--12.48M

--11.77M

--10.33M

--7.68M

R&D expenses

-15.53%7.00M

-73.66%3.20M

-47.53%7.69M

-63.82%5.40M

-42.57%8.29M

-10.26%12.15M

22.28%14.65M

70.46%14.92M

71.20%14.43M

102.12%13.54M

112.76%11.98M

--8.75M

--8.43M

--6.70M

--5.63M

Operating profit

14.71%-10.04M

54.56%-7.22M

36.94%-11.54M

54.25%-8.61M

35.25%-11.77M

4.34%-15.88M

-14.07%-18.30M

-50.81%-18.82M

-54.46%-18.18M

-60.66%-16.60M

-108.76%-16.04M

---12.48M

---11.77M

---10.33M

---7.68M

Net non-operating interest income (expenses)

Non-operating interest income

-45.78%687.00K

-47.82%754.00K

-47.11%888.00K

--1.08M

-13.99%1.27M

81.30%1.45M

134.50%1.68M

----

216.09%1.47M

249.56%797.00K

2551.85%716.00K

--630.00K

--466.00K

--228.00K

--27.00K

Special income (expenses)

----

--9.00K

---2.24M

----

Other non-operating income (expenses)

----

-100.00%0.00

----

47825.00%1.92M

----

--4.00K

---35.00K

---15.00K

---1.00K

Income before tax

26.63%-9.35M

55.23%-6.46M

35.92%-10.65M

55.49%-7.52M

23.70%-12.75M

8.66%-14.44M

-8.44%-16.62M

-42.70%-16.90M

-47.34%-16.71M

-56.17%-15.80M

-100.12%-15.32M

---11.84M

---11.34M

---10.12M

---7.66M

Income after tax

26.63%-9.35M

55.23%-6.46M

35.92%-10.65M

55.49%-7.52M

23.70%-12.75M

8.66%-14.44M

-8.44%-16.62M

-42.70%-16.90M

-47.34%-16.71M

-56.17%-15.80M

-100.12%-15.32M

---11.84M

---11.34M

---10.12M

---7.66M

Net income from continuous operations

26.63%-9.35M

55.23%-6.46M

35.92%-10.65M

55.49%-7.52M

23.70%-12.75M

8.66%-14.44M

-8.44%-16.62M

-42.70%-16.90M

-47.34%-16.71M

-56.17%-15.80M

-100.12%-15.32M

---11.84M

---11.34M

---10.12M

---7.66M

Net income attributable to controlling interests

26.63%-9.35M

55.23%-6.46M

35.92%-10.65M

55.49%-7.52M

23.70%-12.75M

8.66%-14.44M

-8.44%-16.62M

-42.70%-16.90M

-47.34%-16.71M

-56.17%-15.80M

-61.72%-15.32M

---11.84M

---11.34M

---10.12M

---9.47M

Preferred share dividend

----

--0.00

-100.00%0.00

--0.00

--1.82M

Net income attributable to common shareholders

26.63%-9.35M

55.23%-6.46M

35.92%-10.65M

55.49%-7.52M

23.70%-12.75M

8.66%-14.44M

-8.44%-16.62M

-42.70%-16.90M

-47.34%-16.71M

-56.17%-15.80M

-61.72%-15.32M

---11.84M

---11.34M

---10.12M

---9.47M

Basic earnings per share

27.68%-0.31

55.75%-0.21

36.54%-0.35

55.61%-0.25

34.43%-0.43

40.29%-0.48

29.37%-0.56

7.13%-0.57

-11.16%-0.65

-54.25%-0.81

-56.11%-0.79

---0.61

---0.59

---0.53

---0.51

Diluted earnings per share

27.68%-0.31

55.75%-0.21

36.54%-0.35

55.61%-0.25

34.43%-0.43

40.29%-0.48

29.37%-0.56

7.13%-0.57

-11.16%-0.65

-54.25%-0.81

-56.11%-0.79

---0.61

---0.59

---0.53

---0.51

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

